37 related articles for article (PubMed ID: 1612812)
1. Left ventricular diastolic function with epirubicin therapy: an echodoppler study.
Maione S; Giunta A; Itri F; Losardo L; Palma M; Giacummo A; De Blasio F; De Matteis L
Int J Clin Pharmacol Ther Toxicol; 1992 Jun; 30(6):189-94. PubMed ID: 1612812
[TBL] [Abstract][Full Text] [Related]
2. Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers.
Mercuro G; Cadeddu C; Piras A; Dessì M; Madeddu C; Deidda M; Serpe R; Massa E; Mantovani G
Oncologist; 2007 Sep; 12(9):1124-33. PubMed ID: 17914082
[TBL] [Abstract][Full Text] [Related]
3. Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers.
Mantovani G; Madeddu C; Cadeddu C; Dessì M; Piras A; Massa E; Serpe R; Antoni G; Mercuro G
Oncologist; 2008 Dec; 13(12):1296-305. PubMed ID: 19060235
[TBL] [Abstract][Full Text] [Related]
4. The effect of landiolol on hemodynamics and left ventricular function in patients with coronary artery disease.
Goto K; Shingu C; Miyamoto S; Miyakawa H; Noguchi T
J Clin Anesth; 2007 Nov; 19(7):523-9. PubMed ID: 18063207
[TBL] [Abstract][Full Text] [Related]
5. [Effect of low dobutamine doses dobutamine on left ventricular diastolic flow parameters in subjects with a low ejection fraction].
Wojtarowicz A; Kaliszczak R; Płońska E; Puchała M; Drechsler D
Przegl Lek; 2002; 59(8):577-9. PubMed ID: 12638323
[TBL] [Abstract][Full Text] [Related]
6. Can the epirubicin cardiotoxicity in cancer patients be prevented by angiotensin converting enzyme inhibitors?
Radulescu D; Buzdugan E; Ciuleanu TE; Todor N; Stoicescu L
J BUON; 2013; 18(4):1052-7. PubMed ID: 24344038
[TBL] [Abstract][Full Text] [Related]
7. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
Minczykowski A; Gryczynska M; Ziemnicka K; Czepczynski R; Sowinski J; Wysocki H
Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular diastolic filling pattern predicts cardiopulmonary determinants of functional capacity in patients with congestive heart failure.
Parthenakis FI; Kanoupakis EM; Kochiadakis GE; Skalidis EI; Mezilis NE; Simantirakis EN; Kanakaraki MK; Vardas PE
Am Heart J; 2000 Aug; 140(2):338-44. PubMed ID: 10925352
[TBL] [Abstract][Full Text] [Related]
9. Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction.
Daugaard G; Lassen U; Bie P; Pedersen EB; Jensen KT; Abildgaard U; Hesse B; Kjaer A
Eur J Heart Fail; 2005 Jan; 7(1):87-93. PubMed ID: 15642537
[TBL] [Abstract][Full Text] [Related]
10. Left ventricular diastolic performance in breast cancer survivors treated with anthracyclines.
Radulescu D; Pripon S; Radulescu LI; Duncea C
Acta Cardiol; 2008 Feb; 63(1):27-32. PubMed ID: 18372577
[TBL] [Abstract][Full Text] [Related]
11. Myocardial function in patients with breast cancer after therapy with anthracyclines and chest irradiation.
Radulescu D; Pripon S; Parv A; Duncea C; Ciuleanu TE; Radulescu LI
J BUON; 2007; 12(3):349-52. PubMed ID: 17918288
[TBL] [Abstract][Full Text] [Related]
12. [Effect of epirubicin on left ventricular function in patients with malignant lymphoma].
Usnarska-Zubkiewicz L; Nowosad H; Grzelak H; Kostecki E; Kotlarek-Haus S
Pol Arch Med Wewn; 1994 Oct; 92(4):322-30. PubMed ID: 7854960
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of peak filling rate for the early identification of daunorubicin cardiotoxicity].
Trappolini M; Matteoli S; Galli V; Grego V
G Ital Cardiol; 1988 Jan; 18(1):55-60. PubMed ID: 3384249
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of epirubicin-induced cardiotoxicity by two-dimensional strain echocardiography in breast cancer patients.
Bi X; Deng Y; Zeng F; Zhu Y; Wu Y; Zhao C; Li C
J Huazhong Univ Sci Technolog Med Sci; 2009 Jun; 29(3):391-4. PubMed ID: 19513629
[TBL] [Abstract][Full Text] [Related]
15. Influence of pharmorubicin on the left ventricular ejection fraction of patients with breast cancer: A mechanism study.
Liu H; Xie MR; Gao H; Li J
J Cancer Res Ther; 2018 Dec; 14(Supplement):S1183-S1187. PubMed ID: 30539868
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular diastolic function by Doppler echocardiography in relation to hormonal replacement therapy in healthy postmenopausal women.
Voutilainen S; Hippeläinen M; Hulkko S; Karppinen K; Ventilä M; Kupari M
Am J Cardiol; 1993 Mar; 71(7):614-7. PubMed ID: 8438755
[No Abstract] [Full Text] [Related]
17. [Evaluation of ventricular function in patients treated with mitoxantrone and 4'-epidoxorubicin].
Avilés A; Díaz-Maqueo JC; Arévila-Ceballos N; García Fernández R; López-Vancell D; Torras V
Arch Inst Cardiol Mex; 1989; 59(6):615-8. PubMed ID: 2624510
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the acute effect of contrast medium on left ventricular function by echocardiography].
Lai WT; Kuo HT; Wang JL; Chang HM; Hwang YS
Gaoxiong Yi Xue Ke Xue Za Zhi; 1986 Jul; 2(7):427-34. PubMed ID: 3482692
[No Abstract] [Full Text] [Related]
19. Echocardiographic evaluation of left ventricular function in patients with ischemic heart disease.
Szabóki F; Märcz I; Vajda G
Acta Cardiol; 1990; 45(6):493-9. PubMed ID: 2072995
[No Abstract] [Full Text] [Related]
20. [Alpha-interferon therapy: an echographic study of left ventricular function and a clinical assessment of cardiovascular complications].
Tarquinii M; Lolli C; Foscoli M; Pinto A; Mazzella G; Labriola E; Roda E; Toschi GP
Ann Ital Med Int; 1992; 7(2):84-6. PubMed ID: 1467128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
